Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Morgan Stanley Upgrades BT To Overweight

Wed, 11th Jan 2017 09:36

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
MORGAN STANLEY RAISES BT GROUP TO 'OVERWEIGHT' ('EQUAL WEIGHT') - PRICE TARGET 490 (450) PENCE
----------
BARCLAYS RAISES BURBERRY TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 1760 (1450) PENCE
----------
HSBC CUTS BURBERRY GROUP PRICE TARGET TO 1630 (1650) PENCE - 'HOLD'
----------
HSBC RAISES MORRISON SUPERMARKETS PRICE TARGET TO 200 (160) PENCE - 'REDUCE'
----------
GOLDMAN RAISES MORRISON SUPERMARKETS PRICE TARGET TO 185 (180) PENCE - 'SELL'
----------
S&P GLOBAL RAISES MORRISON SUPERMARKETS PRICE TARGET TO 200 (180) PENCE - 'STRONG SELL'
----------
HSBC RAISES CAPITA GROUP TO 'HOLD' ('REDUCE') - TARGET 500 (450) PENCE
----------
UBS RAISES UNILEVER PRICE TARGET TO 3460 (3380) PENCE - 'NEUTRAL'
----------
UBS CUTS RECKITT BENCKISER TO 'NEUTRAL' (BUY) - PRICE TARGET 7100 (8000) PENCE
----------
BERENBERG RAISES WPP PRICE TARGET TO 1760 (1620) PENCE - 'HOLD'
----------
EXANE BNP RAISES BP PRICE TARGET TO 590 (520) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SHELL B PRICE TARGET TO 2480 (2250) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BP PRICE TARGET TO 590 (520) PENCE - 'OUTPERFORM'
----------
HSBC RAISES BP PRICE TARGET TO 590 (540) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES RELX PRICE TARGET TO 1560 (1550) PENCE - 'OVERWEIGHT'
----------
TRADERS: JPMORGAN CUTS EASYJET TO 'UNDERWEIGHT' ('NEUTRAL')
----------
BERENBERG RAISES ANTOFAGASTA PRICE TARGET TO 515 (500) PENCE - 'SELL'
----------
Investec Ups Standard Chartered Target To 595p From 580p, Keeps Sell
----------
FTSE 250
----------
CREDIT SUISSE CUTS THOMAS COOK TO 'NEUTRAL' (OUTPERFORM) - TARGET 88 (87) PENCE
----------
Cantor Ups Ted Baker Target To 2,900p From 2,800p, Keeps Buy
----------
N+1 Ups Cineworld Group Target To 650p From 635p, Keeps Buy
----------
Liberum Ups SEGRO Target To 490p From 460p, Keeps Hold
----------
LIBERUM RAISES CRANSWICK PRICE TARGET TO 2600 (2500) PENCE - 'BUY'
----------
HSBC CUTS GREENCORE PRICE TARGET TO 300 (354) PENCE - 'BUY'
----------
HSBC CUTS STAGECOACH GROUP PRICE TARGET TO 205 (225) PENCE - 'HOLD'
----------
HSBC RAISES GO-AHEAD GROUP PRICE TARGET TO 2475 (2335) PENCE - 'BUY'
----------
UBS CUTS BOVIS HOMES PRICE TARGET TO 850 (910) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES JUST EAT PRICE TARGET TO 650 (620) PENCE - 'BUY
----------
BERENBERG CUTS UBM TO 'SELL' ('HOLD') - TARGET 675 (700) PENCE
----------
BERENBERG CUTS INMARSAT PRICE TARGET TO 740 (910) PENCE - 'HOLD'
----------
TRADERS: MERRILL LYNCH CUTS BODYCOTE TO 'UNDERPERFORM' ('BUY')
----------
TRADERS: MERRILL LYNCH RAISES SPECTRIS TO 'BUY' ('UNDERPERFORM')
----------
TRADERS: MERRILL LYNCH RAISES SPIRAX-SARCO TO 'BUY' ('NEUTRAL')
----------
Canaccord Ups KAZ Minerals To Buy From Hold, Target To 475p From 155p
----------
LIBERUM RAISES VICTREX PRICE TARGET TO 2245 (2100) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
Numis Cuts Nichols To Reduce From Hold, Target To 1,368p From 1,380p
----------
Numis Ups Foxtons Group To Buy From Add, Target At 123p
----------
Cantor Ups Liontrust Asset Management Target To 450p From 370p, Keeps Buy
----------
N+1 Ups Liontrust Asset Management Target To 440p From 374p, Keeps Buy
----------
PANMURE RAISES MCBRIDE PRICE TARGET TO 220 (210) PENCE - 'BUY'
----------
PANMURE RAISES ABCAM PRICE TARGET TO 680 (640) PENCE - 'SELL'
----------
finnCap Ups Joules Group Target To 235p From 210p, Keeps Buy
----------
HSBC RAISES JIMMY CHOO PRICE TARGET TO 170 (150) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2017 Alliance News Limited. All Rights Reserved.

More News
31 Jul 2018 15:42

Berenberg changes mind on Abcam, reinstating 'buy' rating

(Sharecast News) - Analysts at Berenberg on Tuesday upgraded their rating for shares of Abcam from 'Hold' to 'Buy' after having downgraded shares of the antibodies supplier just three months ago.

Read more
31 Jul 2018 13:26

Tuesday broker round-up

(Sharecast News) - Abcam: Berenberg upgrades to buy with a target price of 1,640p.

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
9 May 2018 16:16

UPDATE: Horizon Discovery Outlook Strong In Face Of Abcam Pull-Out

LONDON (Alliance News) - Horizon Discovery Group PLC on Wednesday noted Abcam PLC's statement earlier in the day it will not be making an offer for Horizon.The gene modulation company a

Read more
9 May 2018 12:33

Abcam Decides Not To Make An Offer For Horizon Discovery Group

LONDON (Alliance News) - Abcam PLC on Wednesday said it has ended plans to make an offer for Horizon Discovery Group PLC following the latter's release of its annual results and a management a

Read more
2 May 2018 18:25

Horizon Discovery Confirms Rejected "Unsolicited" Abcam Proposal

LONDON (Alliance News) - Genomics firm Horizon Discovery Group PLC on Wednesday confirmed it had rejected an unsolicited and "highly conditional" proposal from Abcam PLC.The life

Read more
2 May 2018 16:41

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

LONDON (Alliance News) - Abcam PLC on Wednesday said gene editing company Horizon Discovery Group PLC has rejected its acquisition proposal.The life science e-commerce company said it a for

Read more
15 Mar 2018 09:53

BROKER RATINGS SUMMARY: Barclays Reviews Banks, Goldman Property Firms

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE WITH

Read more
7 Mar 2018 15:23

FDA head Gottlieb criticizes industry for "Kabuki drug-pricing"

WASHINGTON, March 7 (Reuters) - U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health a

Read more
10 Jan 2017 10:30

Abcam's revenue to be ahead of expectations

(ShareCast News) - Cambridge-based life science company Abcam said it anticipates revenue will continue to grow in the second half of the year, ahead of expectations. The AIM-listed company company expects revenue to grow 10% on a constant currency basis and 30% on a reported basis as it is on track

Read more
24 Oct 2016 10:28

Abcam commits to massive new Cambridge headquarters

(ShareCast News) - Life science research tools supplier Abcam announced on Monday that it has committed to the lease of a new facility for its global headquarters at the Biomedical Campus in Cambridge, subject to the grant of full planning approval. The AIM-traded firm said the purpose-built facilit

Read more
28 Sep 2016 11:29

DIRECTOR DEALINGS: Abcam COO Donates 62,000 Shares to Charity

Read more
12 Sep 2016 10:40

Abcam earnings dip slightly in year of investment

(ShareCast News) - Life science research tool supplier Abcam announced its preliminary results for the year to 30 June on Monday, with catalogue revenue increasing by 17.4% on a reported basis to £159.0m. The AIM-traded firm said at constant exchange rates the increase was 14.4%. Total revenue incr

Read more
2 Sep 2016 10:21

Abcam to place shares on AIM to pay vendors following acquisition

(ShareCast News) - Life science company Abcam is to pay the first performance-based payment of $5.2m for its acquisition of AmioMx through a share placing on AIM, the London Stock Exchange's junior market. The Cambridge-based company bought AmioMx in November 2015 which included an agreement to make

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.